BALMUDA Inc. (TYO:6612)

G1 Therapeutics Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,300	1,345	1,167	1,246	1,000	4,452
Cash & Short-Term Investments	1,300	1,345	1,167	1,246	1,000	4,452
Cash Growth	-4.27%	15.25%	-6.34%	24.60%	-77.54%	256.73%
Receivables	1,437	2,367	2,423	2,660	5,321	2,278
Inventory	1,731	1,465	2,941	4,029	2,761	1,471
Other Current Assets	376	355	362	378	342	100
Total Current Assets	4,844	5,532	6,893	8,313	9,424	8,301
Property, Plant & Equipment	464	464	632	761	743	455
Long-Term Investments	114	35	43	91	106	29
Other Intangible Assets	122	147	203	490	405	125
Long-Term Deferred Tax Assets	-	3	30	251	203	202
Other Long-Term Assets	1	1	2	1	-	1
Total Assets	5,545	6,182	7,803	9,907	10,881	9,113
Accounts Payable	535	717	1,123	1,121	1,763	1,476
Accrued Expenses	53	50	61	89	91	90
Short-Term Debt	100	100	600	800	800	300
Current Portion of Long-Term Debt	225	303	514	330	475	367
Current Income Taxes Payable	-	3	458	-	238	888
Other Current Liabilities	506	634	453	970	1,073	753
Total Current Liabilities	1,419	1,807	3,209	3,310	4,440	3,874
Long-Term Debt	124	25	328	284	148	479
Other Long-Term Liabilities	2	1	1	1	2	1
Total Liabilities	1,545	1,833	3,538	3,595	4,590	4,354
Common Stock	37	90	1,423	1,414	1,407	1,149
Additional Paid-In Capital	2,867	2,759	1,420	1,411	1,404	1,146
Retained Earnings	1,079	1,476	1,409	3,480	3,477	2,462
Comprehensive Income & Other	17	24	13	7	3	2
Shareholders' Equity	4,000	4,349	4,265	6,312	6,291	4,759
Total Liabilities & Equity	5,545	6,182	7,803	9,907	10,881	9,113
Total Debt	449	428	1,442	1,414	1,423	1,146
Net Cash (Debt)	851	917	-275	-168	-423	3,306
Net Cash Per Share	100.44	108.14	-32.61	-19.81	-49.95	494.80
Filing Date Shares Outstanding	8.52	8.46	8.46	8.43	8.38	8.25
Total Common Shares Outstanding	8.52	8.46	8.44	8.38	8.33	7.74
Working Capital	3,425	3,725	3,684	5,003	4,984	4,427
Book Value Per Share	469.32	513.88	505.29	753.08	755.50	615.26
Tangible Book Value	3,878	4,202	4,062	5,822	5,886	4,634
Tangible Book Value Per Share	455.01	496.51	481.24	694.62	706.86	599.10

Source: S&P Global Market Intelligence. Standard template. Financial Sources.